Burning Rock Biotech Limited
BNR
$16.76
-$0.07-0.42%
NASDAQ
| 12/31/2025 | 09/30/2025 | 03/31/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 72.50M | 72.50M | 71.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 72.50M | 72.50M | 71.70M |
| Cost of Revenue | -- | -- | 20.67M | 20.67M | 21.33M |
| Gross Profit | -- | -- | 51.83M | 51.83M | 50.38M |
| SG&A Expenses | -- | -- | 52.53M | 52.53M | 62.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | 101.84M | 101.84M | 116.48M |
| Operating Income | -- | -- | -29.34M | -29.34M | -44.78M |
| Income Before Tax | -- | -- | -32.25M | -32.25M | -47.33M |
| Income Tax Expenses | -- | -- | 823.80K | 823.80K | 818.10K |
| Earnings from Continuing Operations | -- | -- | -33.07 | -33.07 | -48.14 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -33.07M | -33.07M | -48.14M |
| EBIT | -- | -- | -29.34M | -29.34M | -44.78M |
| EBITDA | -- | -- | -16.66M | -16.66M | -29.29M |
| EPS Basic | -- | -- | -32.04 | -32.04 | -46.82 |
| Normalized Basic EPS | -- | -- | -0.75 | -0.75 | -1.67 |
| EPS Diluted | -- | -- | -32.04 | -32.04 | -46.82 |
| Normalized Diluted EPS | -- | -- | -0.75 | -0.75 | -1.67 |
| Average Basic Shares Outstanding | -- | -- | 41.68M | 41.68M | 41.17M |
| Average Diluted Shares Outstanding | -- | -- | 4.17M | 4.17M | 4.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |